[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Books, Journals, New Media
September NaN, 1998

Jews and Medicine

Author Affiliations

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;280(12):1052-1054. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-12-jbk0923

In Reply.—We agree with Dr Berman that insurers vary substantially in the procedures they use to develop and implement policy regarding coverage for new technologies (and other treatments) and in the values they apply in making their decisions. We also agree that many insurers make serious efforts to address the 3 conditions we believe are necessary to create a public sense of legitimacy and fairness for limit-setting policies: (1) articulate the rationale behind their policies, (2) make the rationale public, and (3) provide opportunities for clinicians and members to appeal policies and specific decisions.1 However, even in the outstanding programs we were privileged to study in our research on policymaking, we and the program leaders agreed there was room for significant improvement.

First Page Preview View Large
First page PDF preview
First page PDF preview